BR
Brii Biosciences Limited
BRIBF · OTC
$0.13 +0.00% (+$0.00)
Market Cap ¥628.2M
P/E Ratio -
Div. Yield -
ROE 8.91%
Bulios Fair Price
$0.12
7.7% downside
Trenutna cena
$0.13
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica BRIBF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
50 /100
Fair P/B 0.26x
P/S 34.66x
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 9.39%
Rev. growth 29.45%
FCF growth N/A
Profitability
0 /100
Weak Net margin 1,196.58%
Op. margin 1,632.59%
FCF margin 1,591.41%
Quality
0 /100
Poor ROE 8.91%
ROA 9.19%
Asset turnover 0.01x
Debt
69 /100
Low Current ratio 60.73x
Int. coverage -154.89x
Debt/Equity 0.00x
Stability
16 /100
Unstable Rev. volatility 4,661.91%
EPS volatility 145.72%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BRIBF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Zhi Hong
Employees
75
Headquarters
Beijing
Prihajajoči dogodki
19 MAR.
Earnings
Upcoming earnings report